(Press-News.org) PASADENA, Calif.—In 1969, an exploding fireball tore through the sky over Mexico, scattering thousands of pieces of meteorite across the state of Chihuahua. More than 40 years later, the Allende meteorite is still serving the scientific community as a rich source of information about the early stages of our solar system's evolution. Recently, scientists from the California Institute of Technology (Caltech) discovered a new mineral embedded in the space rock—one they believe to be among the oldest minerals formed in the solar system.
Dubbed panguite, the new titanium oxide is named after Pan Gu, the giant from ancient Chinese mythology who established the world by separating yin from yang to create the earth and the sky. The mineral and the mineral name have been approved by the International Mineralogical Association's Commission on New Minerals, Nomenclature and Classification. A paper outlining the discovery and the properties of this new mineral will be published in the July issue of the journal American Mineralogist, and is available online now.
"Panguite is an especially exciting discovery since it is not only a new mineral, but also a material previously unknown to science," says Chi Ma, a senior scientist and director of the Geological and Planetary Sciences division's Analytical Facility at Caltech and corresponding author on the paper.
The Allende meteorite is the largest carbonaceous chondrite—a diverse class of primitive meteorites—ever found on our planet and is considered by many the best-studied meteorite in history. As a result of an ongoing nanomineralogy investigation of primitive meteorites—which Ma has been leading since 2007—nine new minerals, including panguite, have been found in the Allende meteorite. Some of those new finds include the minerals allendeite, hexamolybdenum, tistarite, and kangite. Nanomineralogy looks at tiny particles of minerals and the minuscule features within those minerals.
"The intensive studies of objects in this meteorite have had a tremendous influence on current thinking about processes, timing, and chemistry in the primitive solar nebula and small planetary bodies," says coauthor George Rossman, the Eleanor and John R. McMillan Professor of Mineralogy at Caltech.
Panguite was observed first under a scanning electron microscope in an ultra-refractory inclusion embedded in the meteorite. Refractory inclusions are among the first solid objects formed in our solar system, dating back to before the formation of Earth and the other planets. "Refractory" refers to the fact that these inclusions contain minerals that are stable at high temperatures and in extreme environments, which attests to their likely formation as primitive, high-temperature liquids produced by the solar nebula.
According to Ma, studies of panguite and other newly discovered refractory minerals are continuing in an effort to learn more about the conditions under which they formed and subsequently evolved. "Such investigations are essential to understand the origins of our solar system," he says.
INFORMATION:
Additional authors on the American Mineralogist paper, "Panguite, (Ti4+,Sc,Al,Mg,Zr,Ca)1.8O3, a new ultra-refractory titania mineral from the Allende meteorite: Synchrotron micro-diffraction and EBSD," are John R. Beckett, senior research scientist at Caltech; Oliver Tschauner from the University of Nevada–Las Vegas; and Wenjun Liu from the Argonne National Laboratory. The study was supported through grants from the National Science Foundation, the U.S. Department of Energy, and NASA's Office of Space Science.
Caltech scientists find new primitive mineral in meteorite
2012-06-27
ELSE PRESS RELEASES FROM THIS DATE:
Duplicate spending on veterans' care costs billions
2012-06-27
(SACRAMENTO, Calif.) — A new study published today in the Journal of the American Medical Association (JAMA) found that the federal government made about $13 billion in duplicative payments to provide health-care services to veterans who were simultaneously enrolled in Medicare Advantage plans from 2004-2009. The study was conducted by researchers at Brown University, VA Palo Alto Medical Center and the Institute for Population Health Improvement at UC Davis Health System.
Some veterans are entitled to health-care coverage through both the U.S. Department of Veterans ...
Health-care law gender gap
2012-06-27
As the Supreme Court prepares to issue its ruling on Thursday, Americans are divided along party, ideology and gender lines on a key provision of the healthcare law.
A new National Agenda Opinion Poll by the University of Delaware's Center for Political Communication reveals women are significantly more likely to support health insurance requirements than men. Additionally, Democrats and liberals overwhelmingly favor insurance mandates, whereas large majorities of Republicans and conservatives oppose them.
The national telephone survey of 906 Americans was conducted ...
Policies to discourage drug trafficking should account for complexity of 'the game'
2012-06-27
CORVALLIS, Ore. – Drug traffickers who want to leave the "game" behind often struggle to do so because they fear loss of power and status, a new study shows.
Those who do leave the illegal drug trade often do so because of a complex mixture of issues including fatherhood, drug use and abuse, and threat of punishment by authorities or fear of retaliation. Researchers concluded that traffickers need ways that allow them to leave the drug business without surrendering their entire identity.
The new article, now online in the International Journal of Drug Policy, is one ...
Moffitt Cancer Center researchers test drug combinations to prevent graft vs. host disease
2012-06-27
Researchers at Moffitt Cancer Center have conducted a clinical trial aimed at preventing graft vs. host disease (GVHD) in patients who have received hematopoietic (blood) cell transplants (HCT). The study, comparing the drug tacrolimus (TAC) in combination with either methotrexate (MTX ) or sirolimus (SIR), found that the sirolimus/tacrolimus (SIR/TAC) combination was more effective in preventing grades II-IV acute GVHD and moderate-severe chronic GVHD after allogeneic blood cell transplantation.
The study randomized 74 patients, ages 16 to 70, to receive either SIR/TAC ...
Jeffrey W. Olin, DO, authors study that describes symptoms and severity of fibromuscular dysplasia
2012-06-27
A patient registry is proving invaluable in cataloging the clinical features, symptoms, severity, and outcomes of fibromuscular dysplasia (FMD), a non-inflammatory vascular disease that can cause narrowing of arteries in the carotid (neck) and renal (kidney) arteries, which can result in headache, strokes, and aneurysms. Registry data revealed that 91 percent of patients are women diagnosed in the prime of their lives. As a result, physicians are developing best practices that can lead to early diagnosis and treatment with the goal of improved outcomes and fewer adverse ...
Research suggests denser development is good for single-family home values
2012-06-27
How do denser neighborhoods affect property values? And what's the economic value of walkable neighborhoods?
A study conducted by researchers at the University of Washington College of Built Environments and a South Korean university shows that, contrary to popular belief, there's a positive association between higher neighborhood density and the value of single-family residential properties.
Researchers modeled the values of single-family homes, multifamily rental buildings, commercial spaces and offices in King County, Wash., which includes Seattle. They used ...
BUSM study finds gout and hyperuricemia on the rise in the US
2012-06-27
(Boston) – Researchers from Boston University School of Medicine (BUSM) have found that the incidence of gout and hyperuricemia (high uric acid levels) in the U.S. has risen significantly over the last 20 years and is associated with major medical disorders like hypertension and chronic kidney disease. The study, which is published in the American Journal of Medicine, was led by Hyon Choi, MD, DrPH, professor of medicine in the section of rheumatology and the clinical epidemiology unit at BUSM and rheumatologist at Boston Medical Center (BMC).
Gout is a common inflammatory ...
Sifting through a trillion electrons
2012-06-27
Modern research tools like supercomputers, particle colliders, and telescopes are generating so much data, so quickly, many scientists fear that soon they will not be able to keep up with the deluge.
"These instruments are capable of answering some of our most fundamental scientific questions, but it is all for nothing if we can't get a handle on the data and make sense of it," says Surendra Byna of the Lawrence Berkeley National Laboratory's (Berkeley Lab's) Scientific Data Management Group.
That's why Byna and several of his colleagues from the Berkeley Lab's Computational ...
Magnet helps target transplanted iron-loaded cells to key areas of heart
2012-06-27
Putnam Valley, NY. (June 26 , 2012) – Optimal stem cell therapy delivery to damaged areas of the heart after myocardial infarction has been hampered by inefficient homing of cells to the damaged site. However, using rat models, researchers in France have used a magnet to guide cells loaded with iron oxide nanoparticles to key sites, enhancing the myocardial retention of intravascularly delivered endothelial progenitor cells.
The study is published in a recent issue of Cell Transplantation (21:4), now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/, ...
Stem cell transplantation into mouse cochlea may impact future hearing loss therapies
2012-06-27
Putnam Valley, NY. (June 26 , 2012) –Researchers in Japan who evaluated the risks and efficacy of transplanting two varieties of stem cells into mouse cochlea have concluded that both adult-derived induced pluripotent stem (iPS) cells and mouse embryonic stem (ES) cells demonstrate similar survival and neural differentiation capabilities. However, there is a risk of tumor growth associated with transplanting iPS cells into mouse cochleae. Given the potential for tumorigenesis, they concluded that the source of iPS cells is a critical issue for iPS cell-based therapy.
Their ...